Logos Global Management LP Talaris Therapeutics, Inc. Transaction History

Logos Global Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.3 - $5.03 $168,070 - $367,562	-73,074 Reduced 26.97%	197,913 $521,000
Q2 2022 Aug 15, 2022	SELL	$4.51 - $9.85 $158,972 - $347,202	-35,249 Reduced 11.51%	270,987 $1.22 Million
Q1 2022 May 16, 2022	SELL	$6.89 - $16.56 $156,933 - $377,187	-22,777 Reduced 6.92%	306,236 $3.01 Million
Q4 2021 Feb 14, 2022	SELL	$12.18 - $17.0 $2.18 Million - $3.04 Million	-178,910 Reduced 35.22%	329,013 $5.03 Million
Q2 2021 Aug 16, 2021	BUY	$12.25 - $18.61 $6.22 Million - $9.45 Million	507,923 New	507,923 $7.46 Million

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.